Edap Tms (NASDAQ:EDAP – Get Free Report) and Semler Scientific (NASDAQ:SMLR – Get Free Report) are both small-cap medical companies, but which is the better business? We will compare the two companies based on the strength of their analyst recommendations, institutional ownership, profitability, valuation, risk, dividends and earnings.
Risk and Volatility
Edap Tms has a beta of 0.43, indicating that its stock price is 57% less volatile than the S&P 500. Comparatively, Semler Scientific has a beta of 0.96, indicating that its stock price is 4% less volatile than the S&P 500.
Profitability
This table compares Edap Tms and Semler Scientific’s net margins, return on equity and return on assets.
| Net Margins | Return on Equity | Return on Assets | |
| Edap Tms | -31.68% | -36.41% | -22.25% |
| Semler Scientific | 25.62% | 21.17% | 19.40% |
Analyst Recommendations
| Sell Ratings | Hold Ratings | Buy Ratings | Strong Buy Ratings | Rating Score | |
| Edap Tms | 0 | 0 | 2 | 0 | 3.00 |
| Semler Scientific | 0 | 0 | 0 | 1 | 4.00 |
Edap Tms presently has a consensus target price of $14.00, indicating a potential upside of 398.22%. Given Edap Tms’ higher probable upside, equities research analysts clearly believe Edap Tms is more favorable than Semler Scientific.
Institutional and Insider Ownership
62.7% of Edap Tms shares are owned by institutional investors. Comparatively, 49.4% of Semler Scientific shares are owned by institutional investors. 0.2% of Edap Tms shares are owned by company insiders. Comparatively, 13.0% of Semler Scientific shares are owned by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock will outperform the market over the long term.
Valuation and Earnings
This table compares Edap Tms and Semler Scientific”s revenue, earnings per share (EPS) and valuation.
| Gross Revenue | Price/Sales Ratio | Net Income | Earnings Per Share | Price/Earnings Ratio | |
| Edap Tms | $62.05 million | 1.68 | -$22.92 million | ($0.54) | -5.20 |
| Semler Scientific | $61.74 million | 2.72 | $20.58 million | $2.79 | 8.52 |
Semler Scientific has lower revenue, but higher earnings than Edap Tms. Edap Tms is trading at a lower price-to-earnings ratio than Semler Scientific, indicating that it is currently the more affordable of the two stocks.
Summary
Semler Scientific beats Edap Tms on 11 of the 15 factors compared between the two stocks.
About Edap Tms
EDAP TMS S.A., together with its subsidiaries, develops, produces, markets, distributes, and maintains a portfolio of minimally invasive medical devices for the treatment of urological diseases in Asia, France, the United States, and internationally. The company operates through High Intensity Focused Ultrasound (HIFU), Extracorporeal ShockWave Lithotripsy (ESWL), and Distribution Services (DIST) segments. The HIFU segment develops, manufactures, and markets medical devices based on HIFU technology for the minimally invasive treatment of urological and other clinical indications. This segment also offers Ablatherm, an ultrasound guided robotic HIFU device for the treatment of organ-confined prostate cancer; and the Focal One, a HIFU robotic device dedicated to the focal therapy of prostate cancer, as well as disposables, and leasing and treatment related services; and maintenance services. The ESWL division manufactures, markets, and services lithotripter for the treatment of urinary tract stones by means of ESWL technology; and offers Sonolith i-move, an extracorporeal shockwave lithotripter, as well as sells disposable parts for lithotripters and electrodes. The Distribution division markets, distributes, and services lasers, micro-ultrasound systems, and other medical products from third parties, as well as leases devices; sells disposables and spare parts; and offers maintenance services. It markets and sells its products through its direct marketing, sales organization, and service platform, as well as through third-party distributors and agents. The company serves hospitals, urology clinics, and research institutions. EDAP TMS S.A. was incorporated in 1979 and is based in Lyon, France.
About Semler Scientific
Semler Scientific, Inc. provides technology solutions to enhance the clinical effectiveness and efficiency of healthcare providers in the United States. The company's products include QuantaFlo, a four-minute in-office blood flow test that enables healthcare providers to use blood flow measurements as part of their examinations of a patient's vascular condition. It also offers Insulin Insights, a software program that is used by a healthcare provider to optimize outpatient insulin dosing. The company's products serve cardiologists, internists, nephrologists, endocrinologists, podiatrists, family practitioners, healthcare insurance plans, integrated delivery networks, independent physician groups, and companies contracting with the healthcare industry, such as risk assessment groups and retailers. It offers its products through sales representatives and distributors. The company was incorporated in 2007 and is headquartered in Santa Clara, California.
Receive News & Ratings for Edap Tms Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Edap Tms and related companies with MarketBeat.com's FREE daily email newsletter.
